| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |